ReP USP - Resultado da busca

Artigo de periodico
Analysis of KIT gene mutations in patients with melanoma of the head and neck mucosa: a retrospective clinical report (2018)
Mendonça, U. B. T. de; Cernea, Claudio Roberto; Matos, L. L; Lima, R. R. M. A
Source: Oncotarget. Unidade: FM
Subjects: MELANOMA, NEOPLASIAS DE CABEÇA E PESCOÇO, MUTAÇÃO GENÉTICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MENDONÇA, U. B. T. de et al. Analysis of KIT gene mutations in patients with melanoma of the head and neck mucosa: a retrospective clinical report. Oncotarget, v. 9, n. 33, p. 22886-22894, 2018Tradução . . Disponível em: https://doi.org/10.18632/oncotarget.25094. Acesso em: 18 nov. 2024.
APA
Mendonça, U. B. T. de, Cernea, C. R., Matos, L. L., & Lima, R. R. M. A. (2018). Analysis of KIT gene mutations in patients with melanoma of the head and neck mucosa: a retrospective clinical report. Oncotarget, 9( 33), 22886-22894. doi:10.18632/oncotarget.25094
NLM
Mendonça UBT de, Cernea CR, Matos LL, Lima RRMA. Analysis of KIT gene mutations in patients with melanoma of the head and neck mucosa: a retrospective clinical report [Internet]. Oncotarget. 2018 ; 9( 33): 22886-22894.[citado 2024 nov. 18 ] Available from: https://doi.org/10.18632/oncotarget.25094
Vancouver
Mendonça UBT de, Cernea CR, Matos LL, Lima RRMA. Analysis of KIT gene mutations in patients with melanoma of the head and neck mucosa: a retrospective clinical report [Internet]. Oncotarget. 2018 ; 9( 33): 22886-22894.[citado 2024 nov. 18 ] Available from: https://doi.org/10.18632/oncotarget.25094
Artigo de periodico
Somatic mutations in early onset luminal breast cancer (2018)
Encinas, G.; Sabelnykova, V. Y.; Lyra, E. C. de; Katayama, Maria Lúcia Hirata; Maistro, S; Valle, P. W. M. V; Pereira, G. F. L; Rodrigues, L. M; Serio, P. A. M. P; Gouvêa, A. C. R. C. de; Pasini, Fatima Solange; Brentani, Maria Mitzi; Chammas, Roger; Folgueira, Maria Aparecida Azevedo Koike
Source: Oncotarget. Unidade: FM
Subjects: NEOPLASIAS MAMÁRIAS, MUTAÇÃO GENÉTICA, JOVENS, GENÔMICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ENCINAS, G. et al. Somatic mutations in early onset luminal breast cancer. Oncotarget, v. 9, n. 32, p. 22460-22479, 2018Tradução . . Disponível em: https://doi.org/10.18632/oncotarget.25123. Acesso em: 18 nov. 2024.
APA
Encinas, G., Sabelnykova, V. Y., Lyra, E. C. de, Katayama, M. L. H., Maistro, S., Valle, P. W. M. V., et al. (2018). Somatic mutations in early onset luminal breast cancer. Oncotarget, 9( 32), 22460-22479. doi:10.18632/oncotarget.25123
NLM
Encinas G, Sabelnykova VY, Lyra EC de, Katayama MLH, Maistro S, Valle PWMV, Pereira GFL, Rodrigues LM, Serio PAMP, Gouvêa ACRC de, Pasini FS, Brentani MM, Chammas R, Folgueira MAAK. Somatic mutations in early onset luminal breast cancer [Internet]. Oncotarget. 2018 ; 9( 32): 22460-22479.[citado 2024 nov. 18 ] Available from: https://doi.org/10.18632/oncotarget.25123
Vancouver
Encinas G, Sabelnykova VY, Lyra EC de, Katayama MLH, Maistro S, Valle PWMV, Pereira GFL, Rodrigues LM, Serio PAMP, Gouvêa ACRC de, Pasini FS, Brentani MM, Chammas R, Folgueira MAAK. Somatic mutations in early onset luminal breast cancer [Internet]. Oncotarget. 2018 ; 9( 32): 22460-22479.[citado 2024 nov. 18 ] Available from: https://doi.org/10.18632/oncotarget.25123
Artigo de periodico
IRS2 silencing increases apoptosis and potentiates the effects of ruxolitinib in JAK2V617F-positive myeloproliferative neoplasms (2016)
Campos, Paula de Melo; Machado Neto, João Agostinho ; Eide, Christopher A.; Savage, Samantha L.; Scopim-Ribeiro, Renata; Duarte, Adriana da Silva Souza; Favaro, Patrícia; Lorand-Metze, Irene; Costa, Fernando F.; Tognon, Cristina E.; Druker, Brian J.; Saad, Sara T. Olalla; Traina, Fabiola
Source: Oncotarget. Unidade: FMRP
Subjects: REAÇÃO EM CADEIA POR POLIMERASE, APOPTOSE, MUTAÇÃO GENÉTICA, LEUCEMIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CAMPOS, Paula de Melo et al. IRS2 silencing increases apoptosis and potentiates the effects of ruxolitinib in JAK2V617F-positive myeloproliferative neoplasms. Oncotarget, v. 7, n. 6, p. 6948-6959, 2016Tradução . . Disponível em: https://doi.org/10.18632/oncotarget.6851. Acesso em: 18 nov. 2024.
APA
Campos, P. de M., Machado Neto, J. A., Eide, C. A., Savage, S. L., Scopim-Ribeiro, R., Duarte, A. da S. S., et al. (2016). IRS2 silencing increases apoptosis and potentiates the effects of ruxolitinib in JAK2V617F-positive myeloproliferative neoplasms. Oncotarget, 7( 6), 6948-6959. doi:10.18632/oncotarget.6851
NLM
Campos P de M, Machado Neto JA, Eide CA, Savage SL, Scopim-Ribeiro R, Duarte A da SS, Favaro P, Lorand-Metze I, Costa FF, Tognon CE, Druker BJ, Saad STO, Traina F. IRS2 silencing increases apoptosis and potentiates the effects of ruxolitinib in JAK2V617F-positive myeloproliferative neoplasms [Internet]. Oncotarget. 2016 ; 7( 6): 6948-6959.[citado 2024 nov. 18 ] Available from: https://doi.org/10.18632/oncotarget.6851
Vancouver
Campos P de M, Machado Neto JA, Eide CA, Savage SL, Scopim-Ribeiro R, Duarte A da SS, Favaro P, Lorand-Metze I, Costa FF, Tognon CE, Druker BJ, Saad STO, Traina F. IRS2 silencing increases apoptosis and potentiates the effects of ruxolitinib in JAK2V617F-positive myeloproliferative neoplasms [Internet]. Oncotarget. 2016 ; 7( 6): 6948-6959.[citado 2024 nov. 18 ] Available from: https://doi.org/10.18632/oncotarget.6851
Artigo de periodico
Exomic sequencing of four rare central nervous system tumor types (2013)
Bettegowda, Chetan; Agrawal, Nishant; Jiao, Yuchen; Wang, Yuxuan; Wood, Laura D; Rodriguez, Fausto J; Hruban, Ralph H; Gallia, Gary L; Binder, Zev A; Riggins, Calle J; Salmasi, Vafi; Riggins, Gregory J; Reitman, Zachary J; Rasheed, Ahmed; Keir, Stephen; Shinjo, Sueli Mieko Oba; Marie, Suely Kazue Nagahashi; McLendon, Roger; Jallo, George; Vogelstein, Bert; Bigner, Darell; Yan, Hai; Kinzler, Kenneth W; Papadopoulos, Nickolas
Source: Oncotarget. Unidade: FM
Subjects: NEOPLASIAS DO SISTEMA NERVOSO (GENÉTICA;MORTALIDADE), SEQUENCIAMENTO GENÉTICO, NEOPLASIAS CEREBRAIS (GENÉTICA;MORTALIDADE), CRIANÇAS, MUTAÇÃO GENÉTICA, NEUROCIRURGIA, RESUMOS (EVENTOS)
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BETTEGOWDA, Chetan et al. Exomic sequencing of four rare central nervous system tumor types. Oncotarget, v. 4, n. 4, p. 572-583, 2013Tradução . . Disponível em: http://www.impactjournals.com/oncotarget/index.php?journal=oncotarget&page=article&op=view&path%5B%5D=964&path%5B%5D=1267. Acesso em: 18 nov. 2024.
APA
Bettegowda, C., Agrawal, N., Jiao, Y., Wang, Y., Wood, L. D., Rodriguez, F. J., et al. (2013). Exomic sequencing of four rare central nervous system tumor types. Oncotarget, 4( 4), 572-583. Recuperado de http://www.impactjournals.com/oncotarget/index.php?journal=oncotarget&page=article&op=view&path%5B%5D=964&path%5B%5D=1267
NLM
Bettegowda C, Agrawal N, Jiao Y, Wang Y, Wood LD, Rodriguez FJ, Hruban RH, Gallia GL, Binder ZA, Riggins CJ, Salmasi V, Riggins GJ, Reitman ZJ, Rasheed A, Keir S, Shinjo SMO, Marie SKN, McLendon R, Jallo G, Vogelstein B, Bigner D, Yan H, Kinzler KW, Papadopoulos N. Exomic sequencing of four rare central nervous system tumor types [Internet]. Oncotarget. 2013 ;4( 4): 572-583.[citado 2024 nov. 18 ] Available from: http://www.impactjournals.com/oncotarget/index.php?journal=oncotarget&page=article&op=view&path%5B%5D=964&path%5B%5D=1267
Vancouver
Bettegowda C, Agrawal N, Jiao Y, Wang Y, Wood LD, Rodriguez FJ, Hruban RH, Gallia GL, Binder ZA, Riggins CJ, Salmasi V, Riggins GJ, Reitman ZJ, Rasheed A, Keir S, Shinjo SMO, Marie SKN, McLendon R, Jallo G, Vogelstein B, Bigner D, Yan H, Kinzler KW, Papadopoulos N. Exomic sequencing of four rare central nervous system tumor types [Internet]. Oncotarget. 2013 ;4( 4): 572-583.[citado 2024 nov. 18 ] Available from: http://www.impactjournals.com/oncotarget/index.php?journal=oncotarget&page=article&op=view&path%5B%5D=964&path%5B%5D=1267
Artigo de periodico
Frequent ATRX, CIC, FUBP1 and IDH1 mutations refine the classification of malignant gliomas (2012)
Jiao, Yuchen; Killela, Patrick J.; Reitman, Zachary J.; Rasheed, B. Ahmed; Heaphy, Christopher M.; Wilde, Roeland F. de; Rodriguez, Fausto J.; Rosemberg, Sergio; Oba-Shinjo, Sueli Meiko; Marie, Suely Kazue Nagahashi; Bettegowda, Chetan; Agrawal, Nishant; Lipp, Eric; Pirozzi, Christopher; Lopez, Giselle; He, Yiping; Friedman, Henry; Friedman, Allan H.; Riggins, Gregory J.; Holdhoff, Matthias; Burger, Peter; McLendon, Roger; Bigner, Darell D.; Vogelstein, Bert; Meeker, Alan K.; Kinzler, Kenneth W.; Papadopoulos, Nickolas; DiazJr., Luis A.; Yan, Hai
Source: Oncotarget. Unidade: FM
Subjects: PROGNÓSTICO, MUTAÇÃO GENÉTICA, NEOPLASIAS CEREBRAIS (DIAGNÓSTICO), ASTRÓCITOS (PATOLOGIA)
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
JIAO, Yuchen et al. Frequent ATRX, CIC, FUBP1 and IDH1 mutations refine the classification of malignant gliomas. Oncotarget, v. 3, n. 7, p. 709-722, 2012Tradução . . Disponível em: https://doi.org/10.18632/oncotarget.588. Acesso em: 18 nov. 2024.
APA
Jiao, Y., Killela, P. J., Reitman, Z. J., Rasheed, B. A., Heaphy, C. M., Wilde, R. F. de, et al. (2012). Frequent ATRX, CIC, FUBP1 and IDH1 mutations refine the classification of malignant gliomas. Oncotarget, 3( 7), 709-722. doi:10.18632/oncotarget.588
NLM
Jiao Y, Killela PJ, Reitman ZJ, Rasheed BA, Heaphy CM, Wilde RF de, Rodriguez FJ, Rosemberg S, Oba-Shinjo SM, Marie SKN, Bettegowda C, Agrawal N, Lipp E, Pirozzi C, Lopez G, He Y, Friedman H, Friedman AH, Riggins GJ, Holdhoff M, Burger P, McLendon R, Bigner DD, Vogelstein B, Meeker AK, Kinzler KW, Papadopoulos N, DiazJr. LA, Yan H. Frequent ATRX, CIC, FUBP1 and IDH1 mutations refine the classification of malignant gliomas [Internet]. Oncotarget. 2012 ; 3( 7): 709-722.[citado 2024 nov. 18 ] Available from: https://doi.org/10.18632/oncotarget.588
Vancouver
Jiao Y, Killela PJ, Reitman ZJ, Rasheed BA, Heaphy CM, Wilde RF de, Rodriguez FJ, Rosemberg S, Oba-Shinjo SM, Marie SKN, Bettegowda C, Agrawal N, Lipp E, Pirozzi C, Lopez G, He Y, Friedman H, Friedman AH, Riggins GJ, Holdhoff M, Burger P, McLendon R, Bigner DD, Vogelstein B, Meeker AK, Kinzler KW, Papadopoulos N, DiazJr. LA, Yan H. Frequent ATRX, CIC, FUBP1 and IDH1 mutations refine the classification of malignant gliomas [Internet]. Oncotarget. 2012 ; 3( 7): 709-722.[citado 2024 nov. 18 ] Available from: https://doi.org/10.18632/oncotarget.588

USP Schools

ReP

Filtros

Authors

USP affiliated authors

Subjects

Indexado em